Tower Research Capital LLC (Trc) Ionis Pharmaceuticals Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,301 shares of IONS stock, worth $149,459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,301
Previous 49,986
91.4%
Holding current value
$149,459
Previous $2.38 Million
92.78%
% of portfolio
0.0%
Previous 0.04%
Shares
27 transactions
Others Institutions Holding IONS
# of Institutions
403Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$523 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$492 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$359 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$304 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$274 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.93B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...